Immunotherapy for glioblastoma: Quo vadis?

Date 09 October 2016
Event ESMO 2016 Congress
Session Moving steps forward: What’s new in the treatment of brain tumours
Topics Cancer Immunology and Immunotherapy
Central Nervous System Malignancies
Presenter Michael Weller
Authors M. Weller
  • Department Of Neurology, Universitätsspital Zürich, 8091 - Zürich/CH